Will the Phase 2 trial "Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy From Brain Hypoxia" reach primary completion on or before Oct 15, 2026?

Resolves Yes if ClinicalTrials.gov record NCT06629324 (Vinmec Research Institute of Stem Cell and Gene Technology) shows an actual primary completion date on or before Oct 15, 2026. Registered date at generation: Oct 15, 2026.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Oct 15, 2026, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.